<i>In silico</i> screening of phytochemical compounds and FDA drugs as potential inhibitors for NSP16/10 5' methyl transferase activity.

Malik, Ashish; Kohli, Mayank; Jacob, Neethu Anju; Kayal, Abhijit; Raj, T Kiran; Kulkarni, Naveen; Chandramohan, Vivek

In silico screening of phytochemical compounds and FDA drugs as potential inhibitors for NSP16/10 5' methyl transferase activity.

Malik, Ashish; Kohli, Mayank; Jacob, Neethu Anju; Kayal, Abhijit; Raj, T Kiran; Kulkarni, Naveen; Chandramohan, Vivek.

Afiliação

Malik A; Quantumzyme LLP, Bangalore, India.
Kohli M; Biotechnology Skill Enhancement Programme, Department of Biotechnology, Siddaganga Institute of Technology, Karnataka, India.
Jacob NA; Biotechnology Skill Enhancement Programme, Department of Biotechnology, Siddaganga Institute of Technology, Karnataka, India.
Kayal A; Quantumzyme LLP, Bangalore, India.
Raj TK; Quantumzyme LLP, Bangalore, India.
Kulkarni N; Quantumzyme LLP, Bangalore, India.
Chandramohan V; Department of Biotechnology, Siddaganga Institute of Technology, Karnataka, India.

J Biomol Struct Dyn ; 41(1): 221-233, 2023 01.

Article em En | MEDLINE | ID: mdl-34844519

Assuntos

COVID-19; Infecções por HIV; Humanos; SARS-CoV-2/metabolismo; Metiltransferases; S-Adenosilmetionina; Simulação de Dinâmica Molecular; Compostos Fitoquímicos/farmacologia; Simulação de Acoplamento Molecular; Inibidores de Proteases/farmacologia

Palavras-chave

COVID-19; dynamics; in silico; interfacial; methyltransferases; simulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / COVID-19 Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google